Khosla Ventures
Listed as “Stylus Medicine”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Company website description: Stylus Medicine, Inc. is a biotechnology company dedicated to developing transformative in vivo genetic medicines.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Listed as “Stylus Medicine”
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.